Small molecules that modulate CoA synthesis or mimic CoAlation on TXNRD2 could potentially be developed as ferroptosis inhibitors specifically targeting the redox status of mitochondria, especially for neurodegenerative diseases in which ferroptosis plays a pathogenic role (50). Here, TXNRD2 is linked to neurodegenerative disease.